Pregnancy outcomes after maternal exposure to rituximab
Chakravarty, Eliza F., Murray, Elaine R., Kelman, Ariella, Farmer, Pamela
Published in Blood (03.02.2011)
Published in Blood (03.02.2011)
Get full text
Journal Article
Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC-0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor
Herman, Ann E, Chinn, Leslie W, Kotwal, Shweta G, Murray, Elaine R, Zhao, Rui, Florero, Marilyn, Lin, Alyse, Moein, Anita, Wang, Rena, Bremer, Meire, Kokubu, Serika, Serone, Adrian P, Hanze, Eva L, Viberg, Anders, Morimoto, Alyssa M, Winter, Helen R, Katsumoto, Tamiko R
Published in Clinical pharmacology and therapeutics (01.06.2018)
Published in Clinical pharmacology and therapeutics (01.06.2018)
Get more information
Journal Article
Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors
Infante, Jeffrey R, Hollebecque, Antoine, Postel-Vinay, Sophie, Bauer, Todd M, Blackwood, Elizabeth M, Evangelista, Marie, Mahrus, Sami, Peale, Franklin V, Lu, Xuyang, Sahasranaman, Srikumar, Zhu, Rui, Chen, Yuan, Ding, Xiao, Murray, Elaine R, Schutzman, Jennifer L, Lauchle, Jennifer O, Soria, Jean-Charles, LoRusso, Patricia M
Published in Clinical cancer research (15.05.2017)
Published in Clinical cancer research (15.05.2017)
Get full text
Journal Article